What Fueled The Previous Growth In The Point-of-Care (POC) Coagulation Testing Devices Market?
The point-of-care (poc) coagulation testing devices market has seen considerable growth due to a variety of factors.
• The point-of-care (POC) coagulation testing devices market has seen substantial growth in recent years. It will rise from $2.12 billion in 2024 to $2.33 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%.
The growth is attributed to the rising prevalence of chronic and infectious diseases, an aging population, the increasing use of portable miniaturized devices, the growing popularity of biomarker profiling, and the demand for personalized medicine.
How Does the Forecast Look for the Point-of-Care (POC) Coagulation Testing Devices Market?
The point-of-care (poc) coagulation testing devices market is expected to maintain its strong growth trajectory in upcoming years.
• The point-of-care (POC) coagulation testing devices market is expected to grow strongly, reaching $3.36 billion by 2029 with a CAGR of 9.7%.
This growth is driven by the demand for rapid disease diagnosis, wellness trends, on-site testing, infectious disease outbreaks, and telemedicine expansion. Trends include next-gen sequencing, RNA analysis, microfluidic technologies, and AI-driven data analytics.
What Are The Leading Drivers Of Growth In The Point-of-Care (POC) Coagulation Testing Devices Market?
The surge in blood clotting disorders is anticipated to spur the expansion of the point-of-care (POC) coagulation testing devices market in the future. The ability of the blood to form clots correctly is hindered by these disorders. Lifestyle behaviors such as smoking, heavy alcohol consumption, and a lack of physical activity can contribute to blood clotting disorders. These factors can impact the health of blood vessels, levels of clotting factors, and blood flow, thus escalating the chances of irregular clotting. POC coagulation testing devices allow medical professionals to rapidly determine a patient's coagulation status, making immediate modifications to medication levels and treatment strategies feasible. For example, as per the yearly global survey by the World Federation of Hemophilia, a Canadian international non-profit organization, in October 2023, there were 427,685 people affected by bleeding disorders in 2022, including 257,146 hemophilia patients, of which 208,957 suffered from Hemophilia A, 42,203 had Hemophilia B, and 5,986 had an undetermined type of hemophilia. Furthermore, 70,034 individuals have different bleeding disorders. Therefore, the escalating prevalence of blood clotting disorders fuels the expansion of the point-of-care (POC) coagulation testing devices market.
How Are The Segments Defined Within The Global Point-of-Care (POC) Coagulation Testing Devices Market?
The point-of-care (POC) coagulation testing devices market covered in this report is segmented –
1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas And Electrolyte Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users
Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)
Pre-Book The Point-of-Care (POC) Coagulation Testing Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Point-of-Care (POC) Coagulation Testing Devices Market?
Prominent businesses in the point-of-care (POC) coagulation testing devices sphere are striving to advance diagnostics and management of coagulation conditions by developing immunofluorescence-based quantitative analyzers. Such analyzers serve as diagnostic tools that measure and quantify distinct proteins or molecules required in coagulation, thus assisting in accurately diagnosing and managing blood clotting abnormalities. To illustrate, Cipla Limited, a pharmaceutical company hailing from India, introduced Cippoint in January 2023. Utilizing immunofluorescence technology, this quantitative analyzer delivers prompt and precise test results within 3 to 15 minutes, thereby expediting the clinical decision-making process. With attributes like an easy-to-navigate interface, swift response time, and extensive testing functionalities, Cippoint plays a crucial role in augmenting diagnostic efficiency, allowing for prompt clinical verdicts, and advancing patient care outcomes.
Who Are the Key Players In The Point-of-Care (POC) Coagulation Testing Devices Market?
Major companies operating in the point-of-care (POC) coagulation testing devices market are:
• Roche Diagnostics
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Medtronic plc
• Siemens Healthineers
• Koninklijke Philips N.V.
• Bio-Rad Laboratories Inc.
• Werfen
• Haemonetics Corporation
• Sonora Quest Laboratories
• 23andMe Holding Co
• Thorne HealthTech Inc.
• Metropolis Healthcare Limited
• Color Health Inc.
• LetsGetChecked Inc.
• Ambry Genetics Corporation
• MyHeritage Ltd.
• Genova Diagnostics Inc.
• Everlywell Inc.
• Complete Genomics Incorporated
• DanteLabs Inc.
• HemoSonics LLC
• Gene by Gene Ltd.
• Veritas Intercontinental
• DirectLabs LLC
• Full Genomes Corporation Inc.
• Ulta Lab Tests LLC
• WellnessFX Inc.
• Any Lab Test Now Inc.
What Is The Most Dominant Region In The Point-of-Care (POC) Coagulation Testing Devices Market?
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2024. The regions covered in the point-of-care (POC) coagulation testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
